Prostate Cancer

Prostate cancer is the second most common cancer in men. It usually grows very slowly and is unlikely to cause serious problems unless it spreads to other parts of the body. Western dietary patterns rich in dairy products seem to increase the risk of prostate cancer.

Quick Answer

What it is

Prostate cancer is the second most common cancer in men. It usually grows very slowly and is unlikely to cause serious problems unless it spreads to other parts of the body.

Key findings

  • Grade A: Testosterone Suppression (Degarelix (Firmagon))
  • Grade A: PSA Suppression (Degarelix (Firmagon))
  • Grade A: PSA Progression-Free Survival (Degarelix (Firmagon))

Safety

  • Western dietary patterns rich in dairy products seem to increase the risk of prostate cancer.
ℹ️ Quick Facts

Quick Facts: Prostate Cancer

  • Supplements Studied:11
  • Research Trials:8
  • Total Participants:101,884
  • Top Supplement:Vitamin E (C)
8 trials
101,884 ppts
11 supps Β· 34 outcomes

Evidence-Based Protocol

Supplement stack ranked by research quality

Moderate Evidence

Primary Stack (Tier 1)

500mg daily

Inhibits androgen receptor signaling and induces apoptosis in prostate cells

16 studies | 1,212 participants

Supporting Stack (Tier 2)

See product label

Supports prostate cancer through multiple complementary pathways

69 studies | 3,574 participants
800mg daily

Supports prostate cancer through multiple complementary pathways

16 studies | 920 participants
555IU daily

Provides antioxidant protection against lipid peroxidation in prostate tissue

8 studies | 258,664 participants
600mg daily

Supports prostate cancer through multiple complementary pathways

2 studies | 72 participants

How It Works

This supplement protocol targets multiple biological pathways, which plays a central role in overall health and wellbeing. When this pathway functions optimally, the body maintains better prostate cancer outcomes through improved cellular signaling and reduced physiological stress. Cancer development involves complex cellular mutations, immune evasion, and metabolic reprogramming of affected tissues.

flavonoids serves as the foundation of this protocol. It inhibits androgen receptor signaling and induces apoptosis in prostate cells. ketogenic-diet complements this approach by supports prostate cancer through multiple complementary pathways. Punicalagins complements this approach by supports prostate cancer through multiple complementary pathways. Vitamin E complements this approach by provides antioxidant protection against lipid peroxidation in prostate tissue.

Good clinical evidence supports this combination approach. By addressing multiple points along the multiple pathway, these supplements work synergistically to produce better results than any single intervention alone. The combined effect helps restore balance to systems that become dysregulated in prostate cancer.

Rather than masking symptoms like conventional medications, these natural compounds support your body's intrinsic healing mechanisms and regulatory systems.

Initial improvements may be noticed within 4-6 weeks, with continued benefits developing over 2-3 months. Consistency is key. For best results, take with meals to enhance absorption unless otherwise directed and maintain regular daily use.

Generated from peer-reviewed researchSchema v

Detailed Outcomes

Grade:
Effect:
Size:
Sort:
|
A
Testosterone Suppression
Phase III: 97.2% achieve T ≀0.5 ng/mL. 96% castrate by day 3 (vs 0% leuprolide). Fastest testosterone suppression among ADT options.
large↓Improves
A
PSA Suppression
Median PSA significantly lower at days 14 and 28 vs leuprolide (p<0.001). Faster PSA decline than GnRH agonists.
large↓Improves
A
PSA Progression-Free Survival
Extension trial showed statistically significant PSA PFS benefit for degarelix over leuprolide with 27.5-month median follow-up.
moderate↑Improves
A
Disease Control
Pooled analysis of 5 RCTs confirms non-inferior disease control. Better S-ALP control suggests improved bone metastases management.
large↑Improves
A
Flare Prevention
No testosterone flare by design (antagonist mechanism). Eliminates need for antiandrogen flare protection therapy.
large↑Improves
A
Testosterone Suppression
97.5% achieve castrate testosterone by day 29. Mean T of 12.8 ng/dL from month 2-12. Most potent GnRH agonist with lowest mean testosterone levels.
large↓Improves
A
PSA Suppression
Median PSA reduced by 96.4% at 12 months. Real-world data shows reduction from 117.9 to 8.5 ng/mL at 6 months.
large↓Improves
A
Overall Survival
9-month survival significantly higher than leuprolide (97.0% vs 90.5%; p=0.033). Low nadir testosterone associated with improved OS (p<0.001).
large↑Improves
A
Testosterone Suppression
100% achieve T ≀50 ng/dL by week 4. Mean testosterone 13.1 ng/dL sustained over multiple years. 99-100% maintain castrate levels for 52 weeks.
large↓Improves
A
PSA Suppression
PSA decreased 90% from baseline (83.6 ng/mL) by week 16 (p=0.0001). Sustained suppression over multiple treatment cycles.
large↓Improves
A
Long-term Castration
T <30 ng/dL maintained in 96% at 2 years, 100% at 3-5 years. Single implant maintains castration for up to 30 months.
large↑Improves
A
Testosterone Suppression
Achieves T ≀50 ng/dL in 1 month, ≀20 ng/dL in 3 months. Lower testosterone escape rates compared to some GnRH agonists.
large↓Improves
A
PSA Suppression
Maximum benefit in PSA suppression among GnRH agonists. 82% objective response rate in metastatic disease.
large↓Improves
A
Overall Survival (Prostate)
10-year OS 42.6-86% neoadjuvant, 87% adjuvant to prostatectomy, 49% absolute survival adjuvant to radiotherapy.
large↑Improves
A
Testosterone Suppression
Achieves castrate testosterone levels (<50 ng/dL) in 98%+ of patients. 6-month depot maintains suppression throughout treatment period.
large↓Improves
A
PSA Reduction
Significant PSA reduction in advanced prostate cancer. Comparable efficacy to bilateral orchiectomy in clinical trials.
large↓Improves
A
Disease Progression
Palliative treatment slows disease progression and improves quality of life in advanced prostate cancer.
large↓Improves
C
Cancer Markers
Positive effects on cancer markers in 93% of clinical trials (25/27)
27 studies
small↓Improves
C
PSA Levels
Modest effect in early-stage prostate cancer
2 studies
small↓Improves
C
Nitric Oxide
Small Increase
1 study
small↑Improves
D
Estrogen
No effect
1 study
none
?
Prostate Cancer Risk
2 studies
↓Improves
?
Prostate-Specific Antigen
2 studies
↑Improves
?
Oxidative Stress Biomarkers
1 study
↓Improves
?
Testosterone
1 study
↑Improves
D
Cancer Mortality
No effect
1 study
none
?
Prostate Cancer Risk
3 studies
↓Improves
D
Erections
No effect
1 study
none
?
Prostate Cancer Risk
1 study
↓Improves
?
Prostate Cancer Symptoms
1 study
↓Improves
?
Prostate-Specific Antigen
1 study
↑Improves
?
Quality of Life
1 study
↑Improves
?
Testosterone
1 study
↑Improves
?
Muscle Mass
1 study
↑Improves

Related Conditions

Type 2 Diabetes

3 shared supplements Β· 868 outcomes

Type 2 diabetes (T2D) is a disease in which blood glucose levels are too high. It is characterized by insulin resistance in muscle, fat, and pancreas cells and an inability of the pancreas to manufacture enough insulin to control blood glucose levels. T2D is strongly associated with excess body fat, and weight loss induced by lifestyle changes is extremely effective for treating T2D.

Muscle Recovery

3 shared supplements Β· 219 outcomes

Muscle recovery refers to a reduction in muscle soreness or a return of a muscle’s range of motion, strength, or power to normal levels after fatiguing exercise or muscle damage. Muscle recovery is associated with reductions in markers of muscle damage and inflammation.

Mood Improvement

3 shared supplements Β· 159 outcomes

Mood improvement refers to a beneficial change in one’s temporary mental or emotional state which can include improvements in feelings of anxiety, anger, sadness, relief, positivity, optimism, loneliness, insecurity, happiness, excitement, curiosity, and calmness.

Metabolic Health

3 shared supplements Β· 975 outcomes

Research on metabolism, blood glucose regulation, insulin sensitivity, and metabolic syndrome.

Immune Health

3 shared supplements Β· 409 outcomes

Immune health refers to the body's ability to resist potentially harmful microorganisms such as viruses and bacteria, and includes both innate and acquired immunity.

High Cholesterol

3 shared supplements Β· 553 outcomes

High amounts of low-density lipoproteins cause fatty plaques to build up in the arteries, which restricts blood flow and can cause health problems like a heart attack. Lifestyle factors (e.g., poor diet, smoking) and genetics play a huge role in blood cholesterol levels.

General Liver Health

3 shared supplements Β· 122 outcomes

Liver health refers to the ability of the liver to carry out normal physiological processes including removing toxins from the blood, producing bile, metabolizing macronutrients, regulating red blood cell volume, and producing blood clotting factors.

3 shared supplements Β· outcomes